Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
Globenewswire· 2025-10-29 13:15
New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced therapy, including JAKsNew data confirm durable clinical benefit across multiple higher-order response measures, including CDAI LDA and DAS28 LDA, after Week 28 for at least three months off drugUpdated safety data through Week 38 demonstrate rosnilimab was well-tolerated with no treatment-related serious adverse ev ...
Red Cat to Present at the ThinkEquity Conference
Globenewswire· 2025-10-29 13:07
Core Viewpoint - Red Cat Holdings, Inc. is set to present at the ThinkEquity Conference, highlighting its advanced drone and robotic solutions for defense and national security [1][2]. Company Overview - Red Cat Holdings, Inc. (Nasdaq: RCAT) specializes in advanced all-domain drone and robotic solutions aimed at defense and national security [3]. - The company operates through subsidiaries Teal Drones and FlightWave Aerospace, focusing on American-made hardware and software for military, government, and public safety operations across various domains [3]. - Red Cat's Family of Systems, particularly the Black Widow™, offers significant tactical capabilities in small unmanned aircraft systems (sUAS) [3]. - The company is expanding into maritime operations through Blue Ops, Inc., innovating in uncrewed surface vessels (USVs) to enhance safety and mission effectiveness [3].
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Globenewswire· 2025-10-29 13:06
Core Points - MapLight Therapeutics, Inc. has successfully closed its initial public offering (IPO) of 16,962,500 shares at a price of $17.00 per share, including the full exercise of underwriters' option for an additional 2,212,500 shares [1][3] - The company also completed a concurrent private placement of 476,707 shares at the IPO price to affiliates of Goldman Sachs, which was not registered under the Securities Act [2][3] - The total gross proceeds from both the IPO and private placement amounted to $296.3 million before deducting underwriting discounts and expenses [3] Company Overview - MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on treating patients with central nervous system disorders [6] - The company was founded by leaders in psychiatry and neuroscience to develop circuit-specific pharmacotherapies [6] - Its lead product candidate, ML-007C-MA, is currently in Phase 2 clinical trials for schizophrenia and Alzheimer's disease psychosis [6]
Oxbridge / SurancePlus to Speak at Uncorrelated Cayman 2025
Globenewswire· 2025-10-29 13:00
GRAND CAYMAN, Cayman Islands, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today announced that Chairman and CEO Jay Madhu will speak on the panel “Tokenization and Stablecoins: Building the Bridge Between Traditional Finance and On-Chain Markets” at Uncorrelated Cayman 2025, taking place November 9-11, 2025 at Hotel Indigo Grand Ca ...
Foremost Clean Energy Reports Significant Increase in Uranium Grade from Assays Received for Recent Discovery at its Hatchet Lake Project
Globenewswire· 2025-10-29 13:00
VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) ("Foremost" or the "Company"), is pleased to report final geochemical assay results from its highly successful 2025 winter drill program at its Hatchet Lake Uranium Property ("Hatchet"), located in the eastern Athabasca Basin region of northern Saskatchewan (figure 1). Previously reported results were derived from preliminary radiometric equivalent grades from downhole probing. The final assay ...
Summit State Bank Earns $818,000, or $0.12 Per Diluted Share, in Third Quarter 2025
Globenewswire· 2025-10-29 13:00
Core Insights - Summit State Bank reported a net income of $818,000, or $0.12 per diluted share for Q3 2025, an increase from $626,000, or $0.09 per diluted share in Q3 2024 [1][5][35] - The bank's operating performance was bolstered by higher net interest income and margin expansion, despite ongoing challenges with nonperforming assets [2][5] - The decision to suspend cash dividends for Q3 2025 aims to strengthen the bank's capital base and improve liquidity [2][5] Financial Performance - The annualized return on average assets was 0.32% and return on average equity was 3.25% for Q3 2025, compared to 0.23% and 2.48% respectively in Q3 2024 [4][35] - Net interest margin expanded by 80 basis points to 3.51% in Q3 2025 from 2.71% in Q3 2024 [5][35] - Non-performing assets decreased to $27,978,000 in Q3 2025 from $41,971,000 in Q3 2024 [5][17] Balance Sheet Highlights - Total assets were $1,006,522,000 as of September 30, 2025, down from $1,118,791,000 a year earlier [33][35] - Net loans held for investment decreased by 9% to $838,402,000 compared to $917,367,000 in Q3 2024 [12][35] - Total deposits fell by 11% to $888,784,000 from $1,002,770,000 in Q3 2024 [14][35] Credit Quality - Non-performing assets represented 2.78% of total assets as of September 30, 2025, a decrease from 3.75% a year earlier [17][40] - The allowance for credit losses to total loans held for investment was 1.65% as of September 30, 2025, compared to 1.66% a year earlier [19][40] - The bank recorded net charge-offs of $1,800,000 in Q3 2025, up from $492,000 in Q2 2025 [18][35] Operational Efficiency - Operating expenses decreased to $5,545,000 in Q3 2025 from $6,181,000 in Q3 2024, driven by reductions in commission expenses and employee benefits [11][35] - The efficiency ratio improved to 58.00% in Q3 2025 from 74.45% in Q3 2024 [35][40] - The bank continues to focus on streamlining operations and managing costs effectively [10]
NNIT A/S: NNIT restates its life science segment in its financial reporting structure
Globenewswire· 2025-10-29 13:00
Today, NNIT announces an update to its financial reporting structure to ensure that all Life Sciences customers are fully consolidated under Region Europe, US, and Asia. As a result, all Life Science customers previously reported under Region Denmark irrespective of the business activity will now be included in Region Europe’s profit and loss statement. Going forward, Region Denmark will consist solely of the Public segment and the Private segment, which includes SCALES. The restatement of the Life Sciences ...
Comscore’s 2025 State of Streaming Report Reveals Surging Growth of Both Ad-Supported Platforms and FAST Channels
Globenewswire· 2025-10-29 13:00
45% of Netflix U.S. Households Watch on the Ad-supported Tier Compared to 34% in 2024RESTON, Va., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Comscore, a global leader in measuring and analyzing consumer behaviors, today released its 2025 State of Streaming report, revealing how consumer behavior continues to reshape the streaming landscape. A key finding is that audience expansion in both ad-supported (AVOD) and FAST channels shows no signs of slowing with big gains across the board. Powered by one of the industry’s ...
New Joint Venture Agreement with PayzliPlus
Globenewswire· 2025-10-29 13:00
LAS VEGAS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Innovative Payment Solutions, Inc. (OTC: IPSI) (“IPSI” or the “Company”), a provider of merchant processing and cross-border digital payment solutions, today announced that it has entered into a Joint Venture with Brant Point Solutions LLC, doing business as PayzliPlus, a fintech and open-banking marketing company with a robust network of business relationships across multiple online sectors, including gaming, wagering, sports betting, and casinos. Under the term ...
GoldHaven Advances Drilling at Copecal Gold Project; East Anomaly Phase Completed
Globenewswire· 2025-10-29 13:00
VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. (CSE: GOH | OTCQB: GHVNF | Frankfurt: 4QS) (“GoldHaven” or the “Company”) is pleased to provide an update on ongoing exploration activities at its 100%-owned Copeçal Project in Brazil, where the Company is advancing a 1,200-metre diamond drilling program designed to test key gold-in-soil and geophysical anomalies. Program Highlights Four diamond drill holes completed totaling ~420 metres at the East AnomalyFifth hole co ...